scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.WNEU.2020.08.052 |
P698 | PubMed publication ID | 33348524 |
P2093 | author name string | Michael G Kaplitt | |
J Levi Chazen | |||
Mihaela A Stavarache | |||
P2860 | cites work | Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound | Q27312535 |
Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment | Q27322329 | ||
Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study | Q27334453 | ||
Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain | Q28256330 | ||
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial | Q28307713 | ||
Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound | Q28483834 | ||
MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound | Q30252977 | ||
Characterization of Different Microbubbles in Assisting Focused Ultrasound-Induced Blood-Brain Barrier Opening. | Q30358276 | ||
Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles. | Q30359572 | ||
Non-invasive, Focused Ultrasound-Facilitated Gene Delivery for Optogenetics. | Q30365963 | ||
Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. | Q30385033 | ||
Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo. | Q30387126 | ||
Focused ultrasound-mediated drug delivery through the blood-brain barrier | Q30394357 | ||
Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior | Q30402133 | ||
First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound | Q30418996 | ||
Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound | Q30447740 | ||
Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma | Q30448863 | ||
Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening. | Q30457601 | ||
Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier | Q30472787 | ||
Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures | Q30475459 | ||
Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q30500905 | ||
Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances | Q30859319 | ||
Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease | Q33582089 | ||
Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model | Q33603862 | ||
Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound | Q34003611 | ||
Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model | Q34043432 | ||
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial | Q34640765 | ||
Liposomal drug delivery systems: an update review. | Q34708849 | ||
Laser Interstitial Thermal Therapy for Mesial Temporal Lobe Epilepsy. | Q36196977 | ||
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease | Q36288717 | ||
DREADDs for Neuroscientists | Q36595793 | ||
Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound | Q37725032 | ||
Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model | Q38703346 | ||
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease | Q38839079 | ||
Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery | Q38864446 | ||
SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery | Q39190110 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Magnetic Enhancement of Stem Cell-Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood-Brain Barrier | Q44516296 | ||
Targeting of microbubbles: contrast agents for ultrasound molecular imaging. | Q47234214 | ||
Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth | Q47861615 | ||
Stereotactic Laser Amygdalohippocampotomy for Mesial Temporal Lobe Epilepsy. | Q50107438 | ||
Emerging Strategies and Future Perspective in Neuro-Oncology Using Transcranial Focused Ultrasonography Technology | Q57166366 | ||
Noninvasive delivery of an α-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound | Q59351729 | ||
Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound | Q61135580 | ||
Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT) | Q90727985 | ||
Transcranial Magnetic Resonance-Guided Focused Ultrasound Surgery for Brain Tumor Ablation: Are We Ready for This Challenging Treatment? | Q91386920 | ||
Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease | Q91387264 | ||
Electromagnetic Regulation of Cell Activity | Q91699721 | ||
Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound | Q91873814 | ||
Influence of Nanobubble Concentration on Blood-Brain Barrier Opening Using Focused Ultrasound Under Real-Time Acoustic Feedback Control | Q91895860 | ||
Focused ultrasound-induced blood brain-barrier opening enhanced vascular permeability for GDNF delivery in Huntington's disease mouse model | Q91958488 | ||
Amelioration of the nigrostriatal pathway facilitated by ultrasound-mediated neurotrophic delivery in early Parkinson's disease | Q92890749 | ||
Ultrasound-mediated blood-brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody | Q93024737 | ||
Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity | Q93380197 | ||
P921 | main subject | MR-guided focused ultrasound | Q50335251 |
P304 | page(s) | 581-589 | |
P577 | publication date | 2021-01-01 | |
P1433 | published in | World Neurosurgery | Q26853866 |
P1476 | title | Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders | |
P478 | volume | 145 |
Search more.